KNC Laboratories (6568) 주식 개요는 일본에서 유기 화학 물질의 연구, 개발 및 생산 솔루션을 제공하는 회사입니다. 자세히 보기6568 펀더멘털 분석스노우플레이크 점수가치 평가0/6미래 성장0/6과거 실적0/6재무 건전성0/6배당1/6위험 분석최신 재무 보고서가 1년 이상 지났습니다.의미 있는 시가총액이 없습니다(¥9B)모든 위험 점검 보기6568 Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair ValueJP¥Current PriceJP¥1.15k14.4% 고평가 내재 할인율Growth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture05b2016201920222025202620282031Revenue JP¥4.6bEarnings JP¥432.7mAdvancedSet Fair ValueView all narrativesKNC Laboratories Co., Ltd. 경쟁사Daishin ChemicalLtdSymbol: TSE:4629Market cap: JP¥8.7bKimotoSymbol: TSE:7908Market cap: JP¥10.0bNankai Chemical CompanyLimitedSymbol: TSE:4040Market cap: JP¥8.0bUltrafabrics HoldingsLtdSymbol: TSE:4235Market cap: JP¥10.7b가격 이력 및 성과KNC Laboratories 주가의 최고가, 최저가 및 변동 요약과거 주가현재 주가JP¥1,148.0052주 최고가JP¥1,418.0052주 최저가JP¥994.00베타01개월 변동-9.39%3개월 변동-9.89%1년 변동13.66%3년 변동-24.42%5년 변동-18.47%IPO 이후 변동-69.55%최근 뉴스 및 업데이트공시 • May 15KNC Laboratories Co., Ltd., Annual General Meeting, Jun 24, 2026KNC Laboratories Co., Ltd., Annual General Meeting, Jun 24, 2026.공시 • May 10KNC Laboratories Co., Ltd. to Report Fiscal Year 2026 Results on May 14, 2026KNC Laboratories Co., Ltd. announced that they will report fiscal year 2026 results on May 14, 2026Upcoming Dividend • Mar 23Upcoming dividend of JP¥17.00 per shareEligible shareholders must have bought the stock before 30 March 2026. Payment date: 25 June 2026. Trailing yield: 2.6%. Lower than top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (2.3%).공시 • Dec 02KNC Laboratories Co., Ltd. to Report Q3, 2026 Results on Feb 13, 2026KNC Laboratories Co., Ltd. announced that they will report Q3, 2026 results on Feb 13, 2026공시 • Oct 07KNC Laboratories Co., Ltd. to Report Q2, 2026 Results on Nov 14, 2025KNC Laboratories Co., Ltd. announced that they will report Q2, 2026 results on Nov 14, 2025Upcoming Dividend • Sep 22Upcoming dividend of JP¥16.00 per shareEligible shareholders must have bought the stock before 29 September 2025. Payment date: 08 December 2025. Trailing yield: 2.8%. Lower than top quartile of Japanese dividend payers (3.6%). In line with average of industry peers (2.6%).더 많은 업데이트 보기Recent updates공시 • May 15KNC Laboratories Co., Ltd., Annual General Meeting, Jun 24, 2026KNC Laboratories Co., Ltd., Annual General Meeting, Jun 24, 2026.공시 • May 10KNC Laboratories Co., Ltd. to Report Fiscal Year 2026 Results on May 14, 2026KNC Laboratories Co., Ltd. announced that they will report fiscal year 2026 results on May 14, 2026Upcoming Dividend • Mar 23Upcoming dividend of JP¥17.00 per shareEligible shareholders must have bought the stock before 30 March 2026. Payment date: 25 June 2026. Trailing yield: 2.6%. Lower than top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (2.3%).공시 • Dec 02KNC Laboratories Co., Ltd. to Report Q3, 2026 Results on Feb 13, 2026KNC Laboratories Co., Ltd. announced that they will report Q3, 2026 results on Feb 13, 2026공시 • Oct 07KNC Laboratories Co., Ltd. to Report Q2, 2026 Results on Nov 14, 2025KNC Laboratories Co., Ltd. announced that they will report Q2, 2026 results on Nov 14, 2025Upcoming Dividend • Sep 22Upcoming dividend of JP¥16.00 per shareEligible shareholders must have bought the stock before 29 September 2025. Payment date: 08 December 2025. Trailing yield: 2.8%. Lower than top quartile of Japanese dividend payers (3.6%). In line with average of industry peers (2.6%).공시 • Jun 04KNC Laboratories Co., Ltd. to Report Q1, 2026 Results on Aug 08, 2025KNC Laboratories Co., Ltd. announced that they will report Q1, 2026 results on Aug 08, 2025공시 • May 13KNC Laboratories Co., Ltd., Annual General Meeting, Jun 24, 2025KNC Laboratories Co., Ltd., Annual General Meeting, Jun 24, 2025.Upcoming Dividend • Mar 21Upcoming dividend of JP¥17.00 per shareEligible shareholders must have bought the stock before 28 March 2025. Payment date: 26 June 2025. Trailing yield: 2.8%. Lower than top quartile of Japanese dividend payers (3.7%). In line with average of industry peers (2.6%).공시 • Feb 28KNC Laboratories Co., Ltd. to Report Fiscal Year 2025 Results on May 13, 2025KNC Laboratories Co., Ltd. announced that they will report fiscal year 2025 results on May 13, 2025공시 • Jan 17KNC Laboratories Co., Ltd. to Report Q3, 2025 Results on Feb 14, 2025KNC Laboratories Co., Ltd. announced that they will report Q3, 2025 results on Feb 14, 2025Upcoming Dividend • Sep 20Upcoming dividend of JP¥16.00 per shareEligible shareholders must have bought the stock before 27 September 2024. Payment date: 05 December 2024. Trailing yield: 2.6%. Lower than top quartile of Japanese dividend payers (3.8%). In line with average of industry peers (2.4%).공시 • Aug 24KNC Laboratories Co., Ltd. to Report Q2, 2025 Results on Nov 08, 2024KNC Laboratories Co., Ltd. announced that they will report Q2, 2025 results on Nov 08, 2024New Risk • Aug 05New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 5.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Latest financial reports are more than 1 year old (reported March 2016 fiscal period end). Minor Risks Short dividend paying track record (1 year of continuous dividend payments). Share price has been volatile over the past 3 months (5.8% average weekly change). Market cap is less than US$100m (JP¥7.89b market cap, or US$55.4m).공시 • May 25KNC Laboratories Co., Ltd. to Report Q1, 2025 Results on Aug 09, 2024KNC Laboratories Co., Ltd. announced that they will report Q1, 2025 results on Aug 09, 2024공시 • May 15KNC Laboratories Co., Ltd., Annual General Meeting, Jun 25, 2024KNC Laboratories Co., Ltd., Annual General Meeting, Jun 25, 2024.Upcoming Dividend • Mar 21Upcoming dividend of JP¥15.00 per shareEligible shareholders must have bought the stock before 28 March 2024. Payment date: 24 June 2024. Trailing yield: 2.1%. Lower than top quartile of Japanese dividend payers (3.2%). In line with average of industry peers (2.1%).공시 • Mar 15KNC Laboratories Co., Ltd. (TSE:6568) acquired an unknown stake in NapaJen Pharma, Inc. from INCJ, Ltd.KNC Laboratories Co., Ltd. (TSE:6568) acquired an unknown stake in NapaJen Pharma, Inc. from INCJ, Ltd. on March 14, 2024.KNC Laboratories Co., Ltd. (TSE:6568) completed the acquisition of an unknown stake in NapaJen Pharma, Inc. from INCJ, Ltd. on March 14, 2024.공시 • Mar 02KNC Laboratories Co., Ltd. to Report Fiscal Year 2024 Results on May 13, 2024KNC Laboratories Co., Ltd. announced that they will report fiscal year 2024 results on May 13, 2024공시 • Nov 19KNC Laboratories Co., Ltd. to Report Q3, 2024 Results on Feb 09, 2024KNC Laboratories Co., Ltd. announced that they will report Q3, 2024 results on Feb 09, 2024Upcoming Dividend • Sep 21Inaugural dividend of JP¥15.00 per shareEligible shareholders must have bought the stock before 28 September 2023. Payment date: 06 December 2023. This is the first dividend for KNC Laboratories since going public. The average dividend yield among industry peers is 2.5%.공시 • Aug 19KNC Laboratories Co., Ltd. to Report Q2, 2024 Results on Oct 11, 2023KNC Laboratories Co., Ltd. announced that they will report Q2, 2024 results on Oct 11, 2023공시 • Jun 03KNC Laboratories Co., Ltd. to Report Q1, 2024 Results on Aug 10, 2023KNC Laboratories Co., Ltd. announced that they will report Q1, 2024 results on Aug 10, 2023공시 • May 14KNC Laboratories Co., Ltd., Annual General Meeting, Jun 22, 2023KNC Laboratories Co., Ltd., Annual General Meeting, Jun 22, 2023.Upcoming Dividend • Mar 23Inaugural dividend of JP¥18.00 per shareEligible shareholders must have bought the stock before 30 March 2023. Payment date: 26 June 2023. This is the first dividend for KNC Laboratories since going public. The average dividend yield among industry peers is 2.8%.공시 • Dec 17KNC Laboratories Co., Ltd. to Report Q3, 2023 Results on Feb 10, 2023KNC Laboratories Co., Ltd. announced that they will report Q3, 2023 results on Feb 10, 2023Board Change • Nov 16No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 6 non-independent directors. Director of Fine Chemical Division & Director Hidemi Yoshida was the last director to join the board, commencing their role in 2022. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.공시 • Sep 01KNC Laboratories Co., Ltd. to Report Q2, 2023 Results on Nov 11, 2022KNC Laboratories Co., Ltd. announced that they will report Q2, 2023 results on Nov 11, 2022공시 • Jun 02KNC Laboratories Co., Ltd. to Report Q1, 2023 Results on Aug 10, 2022KNC Laboratories Co., Ltd. announced that they will report Q1, 2023 results on Aug 10, 2022공시 • May 18KNC Laboratories Co., Ltd., Annual General Meeting, Jun 23, 2022KNC Laboratories Co., Ltd., Annual General Meeting, Jun 23, 2022.Board Change • Apr 27No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 8 non-independent directors. Director Kimio Yasuda was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.공시 • Apr 08KNC Laboratories Co., Ltd. to Report Fiscal Year 2022 Results on May 13, 2022KNC Laboratories Co., Ltd. announced that they will report fiscal year 2022 results on May 13, 2022Upcoming Dividend • Mar 23Upcoming dividend of JP¥25.00 per shareEligible shareholders must have bought the stock before 30 March 2022. Payment date: 25 June 2022. The company is not currently making a profit and is not cash flow positive. Trailing yield: 2.3%. Lower than top quartile of Japanese dividend payers (3.4%). Lower than average of industry peers (2.6%).Upcoming Dividend • Mar 23Inaugural dividend of JP¥25.00 per shareEligible shareholders must have bought the stock before 30 March 2021. Payment date: 25 June 2021. This is the first dividend for KNC Laboratories since going public. The average dividend yield among industry peers is 1.8%.공시 • Mar 05KNC Laboratories Co., Ltd. to Report Fiscal Year 2021 Results on May 13, 2021KNC Laboratories Co., Ltd. announced that they will report fiscal year 2021 results on May 13, 2021Is New 90 Day High Low • Feb 15New 90-day low: JP¥1,526The company is down 9.0% from its price of JP¥1,678 on 17 November 2020. The Japanese market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 11% over the same period.공시 • Dec 12KNC Laboratories Co., Ltd. to Report Q3, 2021 Results on Feb 12, 2021KNC Laboratories Co., Ltd. announced that they will report Q3, 2021 results on Feb 12, 2021공시 • Sep 13KNC Laboratories Co., Ltd. to Report Q2, 2021 Results on Nov 13, 2020KNC Laboratories Co., Ltd. announced that they will report Q2, 2021 results on Nov 13, 2020공시 • Jun 29KNC Laboratories Co., Ltd. to Report Q1, 2021 Results on Aug 07, 2020KNC Laboratories Co., Ltd. announced that they will report Q1, 2021 results on Aug 07, 2020주주 수익률6568JP ChemicalsJP 시장7D-10.3%-1.8%-0.5%1Y13.7%50.3%39.8%전체 주주 수익률 보기수익률 대 산업: 6568은 지난 1년 동안 50.3%의 수익을 기록한 JP Chemicals 산업보다 저조한 성과를 냈습니다.수익률 대 시장: 6568은 지난 1년 동안 39.8%를 기록한 JP 시장보다 저조한 성과를 냈습니다.주가 변동성Is 6568's price volatile compared to industry and market?6568 volatility6568 Average Weekly Movement6.3%Chemicals Industry Average Movement6.0%Market Average Movement5.0%10% most volatile stocks in JP Market9.6%10% least volatile stocks in JP Market2.5%안정적인 주가: 6568는 지난 3개월 동안 JP 시장에 비해 주가 변동성이 크지 않았습니다.시간에 따른 변동성: 6568의 주간 변동성(6%)은 지난 1년 동안 안정적이었습니다.회사 소개설립직원 수CEO웹사이트1985n/aTakuya Maokawww.kncweb.co.jp는 일본에서 유기 화학 물질의 연구, 개발 및 생산 솔루션에 종사하고 있습니다. 이 회사는 제약, 전자-화학, 농화학, 에너지 및 환경 분야에서 사용할 수 있는 제품을 제공합니다. 의약품 및 기능성 화학 물질에 대한 지원 서비스도 제공합니다.더 보기KNC Laboratories Co., Ltd. 기초 지표 요약KNC Laboratories의 순이익과 매출은 시가총액과 어떻게 비교됩니까?6568 기초 통계시가총액JP¥8.82b순이익 (TTM)JP¥391.00m매출 (TTM)JP¥4.61b0.0x주가수익비율(P/E)0.0x주가매출비율(P/S)6568는 고평가되어 있습니까?공정 가치 및 평가 분석 보기순이익 및 매출최근 실적 보고서(TTM)의 주요 수익성 지표6568 손익계산서 (TTM)매출JP¥4.61b매출원가JP¥3.42b총이익JP¥1.19b기타 비용JP¥802.00m순이익JP¥391.00m최근 보고된 실적Mar 31, 2016다음 실적 발표일해당 없음주당순이익(EPS)0총이익률0.00%순이익률0.00%부채/자본 비율0.0%6568의 장기 실적은 어땠습니까?과거 실적 및 비교 보기배당2.6%현재 배당 수익률n/a배당 성향6568는 안정적으로 배당을 지급합니까?6568 배당 기록 및 벤치마크 보기다가오는 배당을 받으려면 언제까지 6568를 매수해야 하나요?KNC Laboratories 배당 일정배당락일Mar 30 2026배당 지급일Jun 25 2026배당락일까지 남은 일수52 days배당 지급일까지 남은 일수35 days6568는 안정적으로 배당을 지급합니까?6568 배당 기록 및 벤치마크 보기View Valuation기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/20 03:09종가2026/05/20 00:00수익2016/03/31연간 수익2016/03/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스KNC Laboratories Co., Ltd.는 1명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Masao YoshidaIchiyoshi Research Institute Inc.
공시 • May 15KNC Laboratories Co., Ltd., Annual General Meeting, Jun 24, 2026KNC Laboratories Co., Ltd., Annual General Meeting, Jun 24, 2026.
공시 • May 10KNC Laboratories Co., Ltd. to Report Fiscal Year 2026 Results on May 14, 2026KNC Laboratories Co., Ltd. announced that they will report fiscal year 2026 results on May 14, 2026
Upcoming Dividend • Mar 23Upcoming dividend of JP¥17.00 per shareEligible shareholders must have bought the stock before 30 March 2026. Payment date: 25 June 2026. Trailing yield: 2.6%. Lower than top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (2.3%).
공시 • Dec 02KNC Laboratories Co., Ltd. to Report Q3, 2026 Results on Feb 13, 2026KNC Laboratories Co., Ltd. announced that they will report Q3, 2026 results on Feb 13, 2026
공시 • Oct 07KNC Laboratories Co., Ltd. to Report Q2, 2026 Results on Nov 14, 2025KNC Laboratories Co., Ltd. announced that they will report Q2, 2026 results on Nov 14, 2025
Upcoming Dividend • Sep 22Upcoming dividend of JP¥16.00 per shareEligible shareholders must have bought the stock before 29 September 2025. Payment date: 08 December 2025. Trailing yield: 2.8%. Lower than top quartile of Japanese dividend payers (3.6%). In line with average of industry peers (2.6%).
공시 • May 15KNC Laboratories Co., Ltd., Annual General Meeting, Jun 24, 2026KNC Laboratories Co., Ltd., Annual General Meeting, Jun 24, 2026.
공시 • May 10KNC Laboratories Co., Ltd. to Report Fiscal Year 2026 Results on May 14, 2026KNC Laboratories Co., Ltd. announced that they will report fiscal year 2026 results on May 14, 2026
Upcoming Dividend • Mar 23Upcoming dividend of JP¥17.00 per shareEligible shareholders must have bought the stock before 30 March 2026. Payment date: 25 June 2026. Trailing yield: 2.6%. Lower than top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (2.3%).
공시 • Dec 02KNC Laboratories Co., Ltd. to Report Q3, 2026 Results on Feb 13, 2026KNC Laboratories Co., Ltd. announced that they will report Q3, 2026 results on Feb 13, 2026
공시 • Oct 07KNC Laboratories Co., Ltd. to Report Q2, 2026 Results on Nov 14, 2025KNC Laboratories Co., Ltd. announced that they will report Q2, 2026 results on Nov 14, 2025
Upcoming Dividend • Sep 22Upcoming dividend of JP¥16.00 per shareEligible shareholders must have bought the stock before 29 September 2025. Payment date: 08 December 2025. Trailing yield: 2.8%. Lower than top quartile of Japanese dividend payers (3.6%). In line with average of industry peers (2.6%).
공시 • Jun 04KNC Laboratories Co., Ltd. to Report Q1, 2026 Results on Aug 08, 2025KNC Laboratories Co., Ltd. announced that they will report Q1, 2026 results on Aug 08, 2025
공시 • May 13KNC Laboratories Co., Ltd., Annual General Meeting, Jun 24, 2025KNC Laboratories Co., Ltd., Annual General Meeting, Jun 24, 2025.
Upcoming Dividend • Mar 21Upcoming dividend of JP¥17.00 per shareEligible shareholders must have bought the stock before 28 March 2025. Payment date: 26 June 2025. Trailing yield: 2.8%. Lower than top quartile of Japanese dividend payers (3.7%). In line with average of industry peers (2.6%).
공시 • Feb 28KNC Laboratories Co., Ltd. to Report Fiscal Year 2025 Results on May 13, 2025KNC Laboratories Co., Ltd. announced that they will report fiscal year 2025 results on May 13, 2025
공시 • Jan 17KNC Laboratories Co., Ltd. to Report Q3, 2025 Results on Feb 14, 2025KNC Laboratories Co., Ltd. announced that they will report Q3, 2025 results on Feb 14, 2025
Upcoming Dividend • Sep 20Upcoming dividend of JP¥16.00 per shareEligible shareholders must have bought the stock before 27 September 2024. Payment date: 05 December 2024. Trailing yield: 2.6%. Lower than top quartile of Japanese dividend payers (3.8%). In line with average of industry peers (2.4%).
공시 • Aug 24KNC Laboratories Co., Ltd. to Report Q2, 2025 Results on Nov 08, 2024KNC Laboratories Co., Ltd. announced that they will report Q2, 2025 results on Nov 08, 2024
New Risk • Aug 05New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 5.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Latest financial reports are more than 1 year old (reported March 2016 fiscal period end). Minor Risks Short dividend paying track record (1 year of continuous dividend payments). Share price has been volatile over the past 3 months (5.8% average weekly change). Market cap is less than US$100m (JP¥7.89b market cap, or US$55.4m).
공시 • May 25KNC Laboratories Co., Ltd. to Report Q1, 2025 Results on Aug 09, 2024KNC Laboratories Co., Ltd. announced that they will report Q1, 2025 results on Aug 09, 2024
공시 • May 15KNC Laboratories Co., Ltd., Annual General Meeting, Jun 25, 2024KNC Laboratories Co., Ltd., Annual General Meeting, Jun 25, 2024.
Upcoming Dividend • Mar 21Upcoming dividend of JP¥15.00 per shareEligible shareholders must have bought the stock before 28 March 2024. Payment date: 24 June 2024. Trailing yield: 2.1%. Lower than top quartile of Japanese dividend payers (3.2%). In line with average of industry peers (2.1%).
공시 • Mar 15KNC Laboratories Co., Ltd. (TSE:6568) acquired an unknown stake in NapaJen Pharma, Inc. from INCJ, Ltd.KNC Laboratories Co., Ltd. (TSE:6568) acquired an unknown stake in NapaJen Pharma, Inc. from INCJ, Ltd. on March 14, 2024.KNC Laboratories Co., Ltd. (TSE:6568) completed the acquisition of an unknown stake in NapaJen Pharma, Inc. from INCJ, Ltd. on March 14, 2024.
공시 • Mar 02KNC Laboratories Co., Ltd. to Report Fiscal Year 2024 Results on May 13, 2024KNC Laboratories Co., Ltd. announced that they will report fiscal year 2024 results on May 13, 2024
공시 • Nov 19KNC Laboratories Co., Ltd. to Report Q3, 2024 Results on Feb 09, 2024KNC Laboratories Co., Ltd. announced that they will report Q3, 2024 results on Feb 09, 2024
Upcoming Dividend • Sep 21Inaugural dividend of JP¥15.00 per shareEligible shareholders must have bought the stock before 28 September 2023. Payment date: 06 December 2023. This is the first dividend for KNC Laboratories since going public. The average dividend yield among industry peers is 2.5%.
공시 • Aug 19KNC Laboratories Co., Ltd. to Report Q2, 2024 Results on Oct 11, 2023KNC Laboratories Co., Ltd. announced that they will report Q2, 2024 results on Oct 11, 2023
공시 • Jun 03KNC Laboratories Co., Ltd. to Report Q1, 2024 Results on Aug 10, 2023KNC Laboratories Co., Ltd. announced that they will report Q1, 2024 results on Aug 10, 2023
공시 • May 14KNC Laboratories Co., Ltd., Annual General Meeting, Jun 22, 2023KNC Laboratories Co., Ltd., Annual General Meeting, Jun 22, 2023.
Upcoming Dividend • Mar 23Inaugural dividend of JP¥18.00 per shareEligible shareholders must have bought the stock before 30 March 2023. Payment date: 26 June 2023. This is the first dividend for KNC Laboratories since going public. The average dividend yield among industry peers is 2.8%.
공시 • Dec 17KNC Laboratories Co., Ltd. to Report Q3, 2023 Results on Feb 10, 2023KNC Laboratories Co., Ltd. announced that they will report Q3, 2023 results on Feb 10, 2023
Board Change • Nov 16No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 6 non-independent directors. Director of Fine Chemical Division & Director Hidemi Yoshida was the last director to join the board, commencing their role in 2022. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
공시 • Sep 01KNC Laboratories Co., Ltd. to Report Q2, 2023 Results on Nov 11, 2022KNC Laboratories Co., Ltd. announced that they will report Q2, 2023 results on Nov 11, 2022
공시 • Jun 02KNC Laboratories Co., Ltd. to Report Q1, 2023 Results on Aug 10, 2022KNC Laboratories Co., Ltd. announced that they will report Q1, 2023 results on Aug 10, 2022
공시 • May 18KNC Laboratories Co., Ltd., Annual General Meeting, Jun 23, 2022KNC Laboratories Co., Ltd., Annual General Meeting, Jun 23, 2022.
Board Change • Apr 27No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 8 non-independent directors. Director Kimio Yasuda was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
공시 • Apr 08KNC Laboratories Co., Ltd. to Report Fiscal Year 2022 Results on May 13, 2022KNC Laboratories Co., Ltd. announced that they will report fiscal year 2022 results on May 13, 2022
Upcoming Dividend • Mar 23Upcoming dividend of JP¥25.00 per shareEligible shareholders must have bought the stock before 30 March 2022. Payment date: 25 June 2022. The company is not currently making a profit and is not cash flow positive. Trailing yield: 2.3%. Lower than top quartile of Japanese dividend payers (3.4%). Lower than average of industry peers (2.6%).
Upcoming Dividend • Mar 23Inaugural dividend of JP¥25.00 per shareEligible shareholders must have bought the stock before 30 March 2021. Payment date: 25 June 2021. This is the first dividend for KNC Laboratories since going public. The average dividend yield among industry peers is 1.8%.
공시 • Mar 05KNC Laboratories Co., Ltd. to Report Fiscal Year 2021 Results on May 13, 2021KNC Laboratories Co., Ltd. announced that they will report fiscal year 2021 results on May 13, 2021
Is New 90 Day High Low • Feb 15New 90-day low: JP¥1,526The company is down 9.0% from its price of JP¥1,678 on 17 November 2020. The Japanese market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 11% over the same period.
공시 • Dec 12KNC Laboratories Co., Ltd. to Report Q3, 2021 Results on Feb 12, 2021KNC Laboratories Co., Ltd. announced that they will report Q3, 2021 results on Feb 12, 2021
공시 • Sep 13KNC Laboratories Co., Ltd. to Report Q2, 2021 Results on Nov 13, 2020KNC Laboratories Co., Ltd. announced that they will report Q2, 2021 results on Nov 13, 2020
공시 • Jun 29KNC Laboratories Co., Ltd. to Report Q1, 2021 Results on Aug 07, 2020KNC Laboratories Co., Ltd. announced that they will report Q1, 2021 results on Aug 07, 2020
